Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Instrumentation Free Molecular Testing Device Detects TB at POC

By LabMedica International staff writers
Posted on 18 Aug 2025

Tuberculosis (TB) remains a global health crisis, killing more than 1. More...

25 million people annually, with nearly one in three cases undiagnosed. In high-burden, resource-limited regions, current diagnostics face serious challenges: the waxy, lipid-rich cell wall of Mycobacterium tuberculosis (MTB) resists portable lysis methods, gold-standard molecular tests demand costly infrastructure and skilled operators, and sputum collection often deters patients. Now, a new investigational prototype delivers point-of-care MTB detection without instrumentation, electricity, or lab infrastructure.

Seek Labs (Salt Lake City, UT, USA) has developed the MTB SeekIt prototype, built on its proprietary modular SeekIt platform. The test integrates lysis chemistry, extraction, amplification, and detection, all exclusively discovered and validated in-house. The development focused on solving the long-standing barrier of MTB cell wall disruption, achieving a functional prototype in just one quarter. The core innovation lies in a single-step lysis buffer that breaks down MTB cells in 15 minutes at room temperature.

The workflow begins with chemical lysis, followed by Seek Extraction, a membrane-based system that captures MTB DNA without lab tools, yielding more than 70% compared to leading spin-column kits. Next, Seek Amplification detects as few as 10 genomic copies in 30 minutes without thermal cycling. Finally, a molecular lateral flow assay (mLFA) provides visual results, which can be paired with a mobile app for digital analysis. Together, these steps create a fully instrument-free diagnostic test.

Internal validation confirmed that the MTB SeekIt test delivers accurate results in under 60 minutes. Importantly, it avoids reliance on heat, mechanical disruption, or expensive instruments, making it adaptable to low-resource settings. The company emphasizes that the prototype illustrates the flexibility and speed of the SeekIt platform, showing how similar assays can be rapidly created for other high-priority diseases.

Seek Labs is presenting the prototype at the 2025 Next Generation Dx Conference in Washington, D.C. The company is actively pursuing collaborations with ministries of health, TB-focused NGOs, and diagnostics distributors in regions like sub-Saharan Africa and Southeast Asia. Future efforts will focus on clinical validation, regulatory approval, and widespread deployment to close the global TB testing gap.

“TB diagnostics have long been limited by gaps in both infrastructure and innovation that have often meant severe consequences for patient care and public health,” said Jared Bauer, CEO of Seek Labs. “Our rapid, point-of-care SeekIt MTB test is designed to enable molecular-level detection in settings where access to equipment and electricity may be limited.”

Related Links:
Seek Labs


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.